These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 25540092

  • 1. Etiological classification of depression based on the enzymes of tryptophan metabolism.
    Fukuda K.
    BMC Psychiatry; 2014 Dec 24; 14():372. PubMed ID: 25540092
    [Abstract] [Full Text] [Related]

  • 2. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression.
    Miura H, Ozaki N, Sawada M, Isobe K, Ohta T, Nagatsu T.
    Stress; 2008 May 24; 11(3):198-209. PubMed ID: 18465467
    [Abstract] [Full Text] [Related]

  • 3. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
    Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr 29; 35(3):702-21. PubMed ID: 21185346
    [Abstract] [Full Text] [Related]

  • 4. Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later.
    Oxenkrug GF.
    Isr J Psychiatry Relat Sci; 2010 Apr 29; 47(1):56-63. PubMed ID: 20686200
    [Abstract] [Full Text] [Related]

  • 5. Monitoring tryptophan metabolism in chronic immune activation.
    Schröcksnadel K, Wirleitner B, Winkler C, Fuchs D.
    Clin Chim Acta; 2006 Feb 29; 364(1-2):82-90. PubMed ID: 16139256
    [Abstract] [Full Text] [Related]

  • 6. Inflammation and serotonin deficiency in major depressive disorder: molecular docking of antidepressant and anti-inflammatory drugs to tryptophan and indoleamine 2,3-dioxygenases.
    Dawood S, Bano S, Badawy AA.
    Biosci Rep; 2022 May 27; 42(5):. PubMed ID: 35506370
    [Abstract] [Full Text] [Related]

  • 7. [New developments on the serotonin hypothesis of depression: shunt of tryptophan].
    Marazziti D, Baroni S, Picchetti M, Piccinni A, Silvestri S, Dell'Osso L.
    Riv Psichiatr; 2013 May 27; 48(1):23-34. PubMed ID: 23438698
    [Abstract] [Full Text] [Related]

  • 8. A new theory of depression based on the serotonin/kynurenine relationship and the hypothalamicpituitary- adrenal axis.
    Ramírez LA, Pérez-Padilla EA, García-Oscos F, Salgado H, Atzori M, Pineda JC.
    Biomedica; 2018 Sep 01; 38(3):437-450. PubMed ID: 30335249
    [Abstract] [Full Text] [Related]

  • 9. Interaction of the immune-inflammatory and the kynurenine pathways in rats resistant to antidepressant treatment in model of depression.
    Duda W, Curzytek K, Kubera M, Connor TJ, Fagan EM, Basta-Kaim A, Trojan E, Papp M, Gruca P, Budziszewska B, Leśkiewicz M, Maes M, Lasoń W.
    Int Immunopharmacol; 2019 Aug 01; 73():527-538. PubMed ID: 31176083
    [Abstract] [Full Text] [Related]

  • 10. Indoleamine-2,3-Dioxygenase/Kynurenine Pathway as a Potential Pharmacological Target to Treat Depression Associated with Diabetes.
    da Silva Dias IC, Carabelli B, Ishii DK, de Morais H, de Carvalho MC, Rizzo de Souza LE, Zanata SM, Brandão ML, Cunha TM, Ferraz AC, Cunha JM, Zanoveli JM.
    Mol Neurobiol; 2016 Dec 01; 53(10):6997-7009. PubMed ID: 26671617
    [Abstract] [Full Text] [Related]

  • 11. [Depression and inflammation in rheumatic diseases].
    Buras A, Waszkiewicz N, Szulc A.
    Postepy Hig Med Dosw (Online); 2016 Mar 04; 70():162-8. PubMed ID: 26943313
    [Abstract] [Full Text] [Related]

  • 12. Late developmental stage-specific role of tryptophan hydroxylase 1 in brain serotonin levels.
    Nakamura K, Sugawara Y, Sawabe K, Ohashi A, Tsurui H, Xiu Y, Ohtsuji M, Lin QS, Nishimura H, Hasegawa H, Hirose S.
    J Neurosci; 2006 Jan 11; 26(2):530-4. PubMed ID: 16407550
    [Abstract] [Full Text] [Related]

  • 13. Role of the indoleamine-2,3-dioxygenase/kynurenine pathway of tryptophan metabolism in behavioral alterations in a hepatic encephalopathy rat model.
    Jiang X, Xu L, Tang L, Liu F, Chen Z, Zhang J, Chen L, Pang C, Yu X.
    J Neuroinflammation; 2018 Jan 04; 15(1):3. PubMed ID: 29301550
    [Abstract] [Full Text] [Related]

  • 14. Cytokine regulation of tryptophan metabolism in the hypothalamic-pituitary-adrenal (HPA) axis: implications for protective and toxic consequences in neuroendocrine regulation.
    Tu H, Rady PL, Juelich T, Smith EM, Tyring SK, Hughes TK.
    Cell Mol Neurobiol; 2005 Jun 04; 25(3-4):673-80. PubMed ID: 16075385
    [Abstract] [Full Text] [Related]

  • 15. Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.
    Myint AM, Kim YK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan 03; 48():304-13. PubMed ID: 24184687
    [Abstract] [Full Text] [Related]

  • 16. Suppression of Kynurenine 3-Monooxygenase as a Treatment for Triple-negative Breast Carcinoma.
    Sordillo LA, Sordillo PP.
    Anticancer Res; 2023 Dec 03; 43(12):5275-5282. PubMed ID: 38030171
    [Abstract] [Full Text] [Related]

  • 17. [Diagnoses and new therapeutic strategy focused on physiological alteration of tryptophan metabolism].
    Mouri A, Hasegawa M, Kunisawa K, Saito K, Nabeshima T.
    Nihon Yakurigaku Zasshi; 2023 May 01; 158(3):233-237. PubMed ID: 36990795
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The Role of the Kynurenine Signaling Pathway in Different Chronic Pain Conditions and Potential Use of Therapeutic Agents.
    Jovanovic F, Candido KD, Knezevic NN.
    Int J Mol Sci; 2020 Aug 22; 21(17):. PubMed ID: 32842609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.